Evidence map›Paper›PMID 27853915›Full record

ArticleInternational urology and nephrology2017

Renal cell carcinoma: applicability of the apparent coefficient of the diffusion-weighted estimated by MRI for improving their differential diagnosis, histologic subtyping, and differentiation grade.

Yulian Mytsyk, Ihor Dutka, Yuriy Borys, Iryna Komnatska, Iryna Shatynska-Mytsyk, Ammad Ahmad Farooqi, Katarina Gazdikova, Martin Caprnda, Luis Rodrigo, Peter Kruzliak

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in International urology and nephrology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 2 pooled it
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 2 syntheses or guidelines pooled it, 48 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Diagnostic value ofScientific reports · 2022
    Article
  14. Article
  15. Abdominal radiology (New York) · 2021
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 5 countries.

Yulian MytsykDepartment of Urology, Lviv National Medical University, Pekarska str. 69, Lviv, Ukraine. mytsyk.yulian@i.ua.
Ihor DutkaEuroclinic Medical Center, Lviv, Ukraine.
Yuriy BorysDepartment of Urology, Lviv National Medical University, Pekarska str. 69, Lviv, Ukraine.
Iryna KomnatskaEuroclinic Medical Center, Lviv, Ukraine.
Iryna Shatynska-MytsykDepartment of Radiology, Lviv National Medical University, Lviv, Ukraine.
Ammad Ahmad FarooqiLaboratory of Translational Oncology and Personalized Medicine, Rashid Latif Medical College, Lahore, Pakistan.
Katarina GazdikovaDepartment of Nutrition, Faculty of Nursing and Professional Health Studies, Slovak Medical University, Limbova 12, 833 03, Bratislava, Slovak Republic. katarina.gazdikova@szu.sk.
Martin CaprndaUniversity of Oviedo, Central University Hospital of Asturias (HUCA), Oviedo, Spain.
Luis RodrigoUniversity of Oviedo, Central University Hospital of Asturias (HUCA), Oviedo, Spain.
Peter KruzliakDepartment of Chemical Drugs, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Palackeho tr 1946/1, 612 42, Brno, Czech Republic. kruzliakpeter@gmail.com.
Danylo Halytsky Lviv National Medical University · UAHospital Universitario Central de Asturias · ESRashid Latif Medical College · PKSlovak Medical University · SKUniversidad de Oviedo · ESUniversity of Veterinary Sciences Brno · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRenal cell carcinoma (RCC) represents the most common malignant epithelial neoplasm of the kidney. Accurate assessment of the renal masses, defining the histologic subtype and the grade of differentiation of the tumor, is vital to ensure an adequate case management as well as for staging and prognosis. Recently, diffusion-weighted imaging (DWI) magnetic resonance imaging (MRI) tends to be increasingly appealing for the clinicians as an imaging procedure of choice for the diagnosis and staging of the RCC, which is predetermined by several advantages over CT. The goal of the survey was to assess the applicability of the apparent diffusion coefficient (ADC) of the DWI MRI for the differential diagnostics, histologic subtyping, and defining the grade of differentiation of the RCC.

methodsThe study enrolled 288 adult patients with renal lesions: 188 patients with solid RCC-126 patients with clear cell subtype (ccRCC), 32 patients with papillary RCC (pRCC), 30 patients with chromophobe RCC (chRCC); 27 patient with cystic form or RCC (Bosniak cyst, category IV); 32 patients with renal angiomyolipoma (AML); 25 patients with renal oncocytoma (OC); and 16 patients with the renal abscess (AB). In total, 245 lesions were pathologically verified. As a reference, 19 healthy volunteers were included into the study. All patients underwent MRI of the kidneys, involving DWI with subsequent evaluation of the ADC.

resultsThere was a reliable difference (p < 0.05) in mean ADC values between the normal renal parenchyma (NRP), solid RCC of different histologic subtypes and grades, cystic RCC, and benign renal lesions. The mean ADC values obtained in the result of the study were (×10

conclusionThe data received in our study demonstrate a substantial restriction of diffusion of hydrogen molecules in tissues of ccRCC in comparison with the healthy renal parenchyma preconditioned by the greater density of tumor. A statistically significant difference in mean ADC values of ccRCC with different grades of nuclear pleomorphism by Fuhrman was observed: Low-grade tumors showed higher mean ADC values compared to high-grade tumors. The modality of the MRI DWI along with ADC measurement allows to reliably differentiate between the solid RCC of main histologic subtypes and grades, cystic RCC, and the benign renal lesions.

Indexed as

Carcinoma, Renal CellKidneyAdultAgedDiagnosis, DifferentialDiffusion Magnetic Resonance ImagingDimensional Measurement AccuracyFemaleHumansMaleMiddle AgedNeoplasm GradingNeoplasm StagingPatient SelectionPrognosisQuality ImprovementApparent diffusion coefficientDiffusion-weighted imagingMagnetic resonance imagingRenal cell carcinoma

Identifiers

PMID27853915
OpenAlexW2552796845

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.